Yet it is being prescribed for healthy individuals to reduce abdominal fat, improve muscle mass and cognitive health
Addressing GLP-1 Costs: Personalized Care Protects ROI As the GLP-1 conversation evolves, Omada Health is updating its industry FAQs to deliver timely data and insights for virtual care buyers
Ozempic is a GLP-1 receptor agonist, while Mounjaro is a dual GLP-1/GIP agonist
The ODB generally covers seniors (65+), youth and young adults enrolled in OHIP+ (18-24 years old, if not private plan), recipients of Ontario Works or ODSP (social assistance), residents of long-term care, and individuals registered with the Trillium Drug Program
Meyhfer, Jens Aberle: The authors have received honoraria for speaking at symposia, financial support for attending symposia, financial support for educational programs, and consultation from Novo Nordisk